Browse by Hotbed/Location
Filter News
Found 469,090 articles
-
LUNGevity Foundation Kicks Off New Marketing Campaign to Raise Awareness of the Impact of Lung Cancer
6/13/2018
"234" asks the public to help change lung cancer statistics
-
Nicole Fevrier Davis Opens New MindBody Mastery Studio and Adds Psychic Assessments and Neurofeedback to her List of Unique Fitness Training Services
5/1/2018
Psychic personal trainer Nicole Fevrier Davis is slated to open her new studio at 10 Roberts Lane in Ridgefield CT on May 2nd.
-
The week of June 18 to June 22 was bookended by big hiring announcement in the pharma industry. It began with a former Cowen analyst being tapped as chief financial officer of startup Allogene and ended with the retirement announcement of the group worldwide chairman at Johnson & Johnson.
-
Roche announced that its Phase III IMpower 133 clinical trial of Tecentriq (atezolizumab) plus carboplatin and etoposide chemotherapy met its co-primary endpoints.
-
FDA Action Alert: It's a Big Week
6/25/2018
It’s a big week for the U.S. Food and Drug Administration (FDA) with plenty of upcoming decisions including Achaogen, GW Pharma, Merck and more. -
Genentech’s TECENTRIQ in Combination with Chemotherapy Helped People with Previously-Untreated Extensive-Stage Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy
6/25/2018
IMpower133 is the first Phase III study with an immunotherapy-based combination to show improvement in overall survival and progression-free survival in the initial treatment of extensive-stage small cell lung cancer
-
US Patent & Trademark Office Issues New Patent to DenMat for Removable Dental Appliances, Branded Snap-On Smile®
6/25/2018
Results in an improved smile without any need to alter the structure of a patient's existing dentition.
-
Oramed Enrolls First Patient in Its Glucose Clamp Study for Oral Insulin
6/25/2018
Study will provide additional metabolic data on ORMD-0801 in patients with type 1 diabetes
-
Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer
6/25/2018
Results show a positive trend in the secondary endpoint of overall survival, though not reaching statistical significance
-
New Imeglimin Data Demonstrating Pancreatic Beta-Cell Protection Presented at the American Diabetes Association 78th Scientific Sessions
6/25/2018
Imeglimin was observed to protect and preserve human beta-cells from cell death from fructose- and glucose-induced toxicity by inhibiting mitochondrial Permeability Transition Pore opening
-
FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
6/25/2018
Novel Low-Flow Technology Has Demonstrated Efficacy in Obstructive Sleep Apnea Patients
-
Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
6/25/2018
The primary efficacy endpoint, defined in both trials as placebo-corrected change from baseline in A1C after 26 weeks of treatment, was met for all investigated doses of empagliflozin (2.5, 10 and 25 mg).
-
Pulmatrix Announces Positive Top-Line Results from Parts 1 and 2 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole
6/25/2018
All doses were well tolerated in normal healthy volunteers in Parts 1 and 2 at up to 35 mg of itraconazole, the maximal dose planned
-
Lilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster Headache
6/25/2018
American Headache Society (AHS) annual meeting is taking place June 28-July 1 in San Francisco.
-
Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer
6/25/2018
A single administration of topsalysin continues to demonstrate an ability to ablate targeted prostate cancer cells with 10 of 35 patients (29%) demonstrating a clinical response of which 6 patients had a complete ablation with no detectable cancer on targeted biopsy of the treated area.
-
AntiCancer’s Oral Methioninase Overcomes Gemcitabine Resistance in Patient-Like Mouse Models of Pancreatic Cancer
6/25/2018
The new results are to be published in the upcoming issue of Cancer Letters.
-
FDA Accepts Supplemental Biologics License Application for Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy in Advanced Melanoma
6/25/2018
Application Based on Recurrence-Free Survival Data from Pivotal Phase 3 EORTC1325/KEYNOTE-054 Trial
-
GB Sciences Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic Pain
6/25/2018
The nonprovisional patent applications protect formulations for pain and heart disease therapies based on myrcene-containing complex mixtures.
-
Glaukos Announces FDA Approval for the iStent inject® Trabecular Micro-Bypass System
6/25/2018
Next-Generation Device from MIGS Pioneer Offers Ophthalmic Surgeons a Compelling New Treatment Option for Managing Glaucoma Patients’ IOP
-
AbbVie and Calibr announce collaboration for next generation T-cell therapies
6/25/2018
Collaboration will focus on switchable CAR-T therapies aimed primarily at solid tumors